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Background
The substituted hydroxynaphthoquinone atovaquone is a
potent antimalarial drug in use for prevention and therapy,
a fundamental part of the ongoing global medicinal strategy
to control the disastrous infectious disease. Atovaquone
acts via inhibition of the cytochrome bc1 complex (cyt bc1)
and related mutations were linked to parasitic drug-
resistance.
Materials and methods
The molecular binding mode of atovaquone was analysed
by spectroscopy and X-ray crystallography. In addition, a
comprehensive cytochrome b sequence analysis was per-
formed to interpret binding interactions of the drug in
context of sequence conservation of Qo site amino acid
residues [1,2].
Results
We determined the 3.0-Å resolution X-ray structure of
mitochondrial cyt bc1 from Saccharomyces cerevisiae
with atovaquone bound in the catalytic Qo site [1]. The
drug, which has a pKa of 6.9, forms a polarized H-bond
between its ionized hydroxyl group and His181 of the
Rieske protein subunit. Multiple non-polar interactions
with side chains of cytochrome b residues stabilize
hydroxynaphthoquinone and chlorophenyl-cyclohexyl
groups. The cytochrome b sequence analysis showed that
the majority of the interacting residues are conserved, so
that atovaquone binding to the yeast cyt bc1 is likely to
resemble the binding to the complexes of the target
organisms.
Conclusion
The binding mode provides detailed insights in the molecu-
lar basis of broad target spectrum, species-specific efficacies
and acquired resistances. This may aid drug development
to control the spread of drug-resistant parasites.
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